Literature DB >> 26139497

Various features of laparoscopic tailored resection for gastric submucosal tumors: a single institution's results for 168 patients.

Chang In Choi1, Si Hak Lee2, Sun Hwi Hwang2, Dae Hwan Kim3, Tae Yong Jeon1, Dong Heon Kim1, Do Youn Park4.   

Abstract

BACKGROUND: Laparoscopic resection is a standard procedure for gastric submucosal tumors. Herein, we analyzed the features of various laparoscopic approaches.
METHODS: Between January 2007 and November 2013, 168 consecutive patients who underwent laparoscopic resection for gastric submucosal tumors were enrolled. Patients' demographics and clinicopathologic and perioperative data were reviewed retrospectively.
RESULTS: Among the 168 patients, exogastric wedge resection was performed in 99 cases (58.9%), single-port intragastric resection was performed in 30 cases (17.9%), eversion technique was used in 17 cases (10.1%), transgastric resection was performed in 8 cases (4.8%), and single-port wedge resection was performed in 6 cases (3.6%). The remaining cases underwent single-port exogastric wedge resection, laparoscopic and endoscopic cooperative surgery, or major resection. Mean age was 56.8 ± 13.3 years, and body mass index was 24.0 ± 3.2 kg/m(2). Mean operation time was 96.1 ± 58.9 min; laparoscopic proximal gastrectomy had the longest operation time (3 cases, 291.7 ± 129.0 min). In contrast, the laparoscopic eversion technique had the shortest operation time (82.6 ± 32.8 min). Pathologic data revealed a mean tumor size of 2.9 ± 1.2 cm (with a range of 0.8-8.0 cm). Tumors were most common on the body (98 cases, 58.3%), followed by the fundus (44 cases, 26.2%). Exophytic growth occurred in 39 cases (23.2%), endophytic growth occurred in 89 cases (53.0%), and dumbbell-type growth occurred in 40 cases (23.8%). Gastrointestinal stromal tumors occurred in 130 cases (77.4%), and schwannomas occurred in 23 (13.7%). Thirteen patients had postoperative complications (delayed gastric emptying in 5, stricture in 3, bleeding in 3, others in 2). The mean follow-up period was 28.8 ± 20.8 months, and there were three recurrences (1.8%) at 6, 19 and 31 months after the initial surgery.
CONCLUSIONS: For gastric submucosal tumors with appropriate locations and growth types, laparoscopic tailored resection which facilitates safer and more precise resection can be good alternative treatment option.

Entities:  

Keywords:  Gastrectomy; Laparoscopy; Stomach neoplasm; Submucosal tumor; Surgical stapling; Tailored approach

Mesh:

Year:  2015        PMID: 26139497     DOI: 10.1007/s00464-015-4350-3

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  24 in total

1.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

Authors:  R P DeMatteo; J J Lewis; D Leung; S S Mudan; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  Laparoscopic resection of clinically suspected gastric stromal tumors.

Authors:  René Berindoague; Eduard M Targarona; Xavier Feliu; Vicenç Artigas; Carmen Balagué; Aurora Aldeano; Antonio Lahoud; Jordi Navines; Enrique Fernandez-Sallent; Manuel Trias
Journal:  Surg Innov       Date:  2006-12       Impact factor: 2.058

3.  Feasibility and safety of laparoscopic and endoscopic cooperative surgery for gastric submucosal tumors, including esophagogastric junction tumors.

Authors:  Shu Hoteya; Shusuke Haruta; Hisashi Shinohara; Akihiro Yamada; Tsukasa Furuhata; Satoshi Yamashita; Daisuke Kikuchi; Toshifumi Mitani; Osamu Ogawa; Akira Matsui; Toshiro Iizuka; Harushi Udagawa; Mitsuru Kaise
Journal:  Dig Endosc       Date:  2013-12-19       Impact factor: 7.559

4.  Laparoscopic resection of gastrointestinal mesenchymal tumors located in the upper stomach.

Authors:  N Tagaya; H Mikami; K Kubota
Journal:  Surg Endosc       Date:  2004-07-30       Impact factor: 4.584

5.  Laparoscopic resection of a huge intraluminal gastric submucosal tumor located in the anterior wall: eversion method.

Authors:  Woo Jin Hyung; Joon Seok Lim; Jae Ho Cheong; Junuk Kim; Seung Ho Choi; Sung Hoon Noh
Journal:  J Surg Oncol       Date:  2005-02-01       Impact factor: 3.454

6.  Laparoscopic intragastric stapled resection of gastric submucosal tumors located near the esophagogastric junction.

Authors:  N Tagaya; H Mikami; H Kogure; K Kubota; Y Hosoya; H Nagai
Journal:  Surg Endosc       Date:  2001-10-05       Impact factor: 4.584

7.  Laparoscopic approaches to resection of suspected gastric gastrointestinal stromal tumors based on tumor location.

Authors:  A Privette; L McCahill; E Borrazzo; Richard M Single; R Zubarik
Journal:  Surg Endosc       Date:  2007-08-22       Impact factor: 4.584

8.  Tailored-approach of laparoscopic wedge resection for treatment of submucosal tumor near the esophagogastric junction.

Authors:  Kyo Young Song; Seung Nam Kim; Cho Hyun Park
Journal:  Surg Endosc       Date:  2007-05-04       Impact factor: 4.584

Review 9.  Laparoscopic management of gastric gastrointestinal stromal tumors.

Authors:  Juan Correa-Cote; Carlos Morales-Uribe; Alvaro Sanabria
Journal:  World J Gastrointest Endosc       Date:  2014-07-16

10.  Laparoscopic surgery for submucosal tumors located at the esophagogastric junction and the prepylorus.

Authors:  Sun-Hwi Hwang; Do Joong Park; Young Hoon Kim; Kyoung Ho Lee; Hye Seung Lee; Hyung-Ho Kim; Hyuk-Joon Lee; Han-Kwang Yang; Kuhn Uk Lee
Journal:  Surg Endosc       Date:  2008-05-10       Impact factor: 4.584

View more
  2 in total

1.  Laparoscopic and endoscopic cooperative surgery is a feasible treatment procedure for intraluminal gastric gastrointestinal stromal tumors compared to endoscopic intragastric surgery.

Authors:  Toshiyasu Ojima; Masaki Nakamura; Mikihito Nakamori; Katsunari Takifuji; Keiji Hayata; Masahiro Katsuda; Yoh Takei; Hiroki Yamaue
Journal:  Surg Endosc       Date:  2017-06-29       Impact factor: 4.584

2.  Endoscopic Treatment for Gastrointestinal Stromal Tumors in the Upper Gastrointestinal Tract.

Authors:  In Kyung Yoo; Joo Young Cho
Journal:  Clin Endosc       Date:  2020-07-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.